Vivos (RDGL) Cash from Financing Activities (2010 - 2025)
Vivos recorded quarterly Cash from Financing Activities of -$845.0 in Q4 2025, down 100.06% quarter-over-quarter from $1.5 million in Q1 2025, and down 100.06% year-over-year from $1.5 million in Q4 2024.
Vivos' Cash from Financing Activities history runs 15 years deep, the most recent figure standing at -$845.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 100.06% year-over-year to -$845.0; the TTM figure through Dec 2025 stood at $1.5 million (down 34.6% YoY), while the FY2025 annual figure was $1.5 million, down 34.6% from the prior year.
- Cash from Financing Activities came in at -$845.0 for Q4 2025 at Vivos, down from $1.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q1 2021 to a low of -$145000.0 in Q4 2021.
- A 4-year average of $667335.9 and a median of $518580.0 in 2023 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 2420.16% in 2021 and fell as far as 111.56% in 2021.
- Vivos' Cash from Financing Activities stood at -$145000.0 in 2021, then soared by 457.64% to $518580.0 in 2023, then surged by 182.56% to $1.5 million in 2024, then plunged by 100.06% to -$845.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$845.0, $1.5 million, and $1.5 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Vivos | - | - | -3,105.00 | -845.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -845.00 |
| Dec 31, 2025 | -845.00 |
| Mar 31, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Jun 30, 2024 | 709,000.00 |
| Jun 30, 2024 | 709,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 518,580.00 |
| Dec 31, 2023 | 518,580.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Mar 31, 2021 | 1.81 Mn |
| Mar 31, 2021 | 1.81 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Sep 30, 2020 | -50,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | 482,910.00 |
| Jun 30, 2020 | 482,910.00 |
| Mar 31, 2020 | 71,870.00 |
| Mar 31, 2020 | 71,870.00 |
| Dec 31, 2019 | 115,000.00 |
| Dec 31, 2019 | 115,000.00 |
| Sep 30, 2019 | 335,000.00 |
| Sep 30, 2019 | 335,000.00 |
| Jun 30, 2019 | 94,000.00 |
| Jun 30, 2019 | 94,000.00 |
| Mar 31, 2019 | 308,000.00 |
| Mar 31, 2019 | 308,000.00 |
| Dec 31, 2018 | 538,140.00 |
| Dec 31, 2018 | 538,140.00 |
| Sep 30, 2018 | 70,932.00 |
| Sep 30, 2018 | 70,932.00 |
| Jun 30, 2018 | 48,559.00 |
| Jun 30, 2018 | 48,559.00 |
| Mar 31, 2018 | 40,000.00 |
| Mar 31, 2018 | 40,000.00 |
| Dec 31, 2017 | 150,000.00 |
| Dec 31, 2017 | 150,000.00 |
| Jun 30, 2017 | 847,034.00 |
| Jun 30, 2017 | 847,034.00 |
| Mar 31, 2017 | 268,669.00 |
| Mar 31, 2017 | 268,669.00 |
| Dec 31, 2016 | 308,762.00 |
| Dec 31, 2016 | 308,762.00 |
| Sep 30, 2016 | 160,033.00 |
| Sep 30, 2016 | 160,033.00 |
| Jun 30, 2016 | 665,015.00 |
| Jun 30, 2016 | 665,015.00 |
| Mar 31, 2016 | 641,760.00 |
| Mar 31, 2016 | 641,760.00 |
| Dec 31, 2015 | 687,915.00 |
| Dec 31, 2015 | 687,915.00 |
| Sep 30, 2015 | 113,000.00 |
| Sep 30, 2015 | 113,000.00 |
| Jun 30, 2015 | 305,500.00 |
| Jun 30, 2015 | 305,500.00 |
| Mar 31, 2015 | 265,519.00 |
| Mar 31, 2015 | 265,519.00 |
| Dec 31, 2014 | 344,748.00 |
| Dec 31, 2014 | 344,748.00 |
| Sep 30, 2014 | -94,491.00 |
| Sep 30, 2014 | -94,491.00 |
| Jun 30, 2014 | 366,524.00 |
| Jun 30, 2014 | 366,524.00 |
| Mar 31, 2014 | 519,348.00 |
| Mar 31, 2014 | 519,348.00 |
| Dec 31, 2013 | 145,683.00 |
| Dec 31, 2013 | 145,683.00 |
| Sep 30, 2013 | 388,389.00 |
| Sep 30, 2013 | 388,389.00 |
| Jun 30, 2013 | 876,995.00 |
| Jun 30, 2013 | 876,995.00 |
| Mar 31, 2013 | 626,708.00 |
| Mar 31, 2013 | 626,708.00 |
| Dec 31, 2012 | 288,259.00 |
| Dec 31, 2012 | 288,259.00 |
| Sep 30, 2012 | 721,527.00 |
| Sep 30, 2012 | 721,527.00 |
| Jun 30, 2012 | 545,406.00 |
| Jun 30, 2012 | 545,406.00 |
| Mar 31, 2012 | 290,067.00 |
| Mar 31, 2012 | 290,067.00 |
| Dec 31, 2011 | 335,383.00 |
| Dec 31, 2011 | 335,383.00 |
| Sep 30, 2011 | 239,588.00 |
| Sep 30, 2011 | 239,588.00 |
| Jun 30, 2011 | 137,385.00 |
| Jun 30, 2011 | 137,385.00 |
| Mar 31, 2011 | -292,924.00 |
| Mar 31, 2011 | -292,924.00 |
| Dec 31, 2010 | -202,197.00 |
| Dec 31, 2010 | -202,197.00 |
| Sep 30, 2010 | 854,300.00 |
| Sep 30, 2010 | 854,300.00 |